DK0848009T3 - Fremgangsmåde til fremstilling af epirubicin eller syreadditionssalte deraf ud fra daunorubicin - Google Patents

Fremgangsmåde til fremstilling af epirubicin eller syreadditionssalte deraf ud fra daunorubicin

Info

Publication number: DK0848009T3
Authority: DK; Denmark
Prior art keywords: daunosamine; daunomycinone; epirubicin; daunorubicin; group
Prior art date: 1996-12-16

Application number

DK96203554T

Other languages

Danish (da)

English (en)

Inventor

Marcel Van Der Rijst

Johan Wilhelm Scheeren

Dick De Vos

Original Assignee

Pharmachemie Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-16

Filing date

1996-12-16

Publication date

2000-11-20

1996-12-16 Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv

2000-11-20 Application granted granted Critical

2000-11-20 Publication of DK0848009T3 publication Critical patent/DK0848009T3/da

Links

AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 title abstract 3
STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 title abstract 3
HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 title abstract 3
229960000975 daunorubicin Drugs 0.000 title abstract 3
STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 title abstract 3
229960001904 epirubicin Drugs 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
239000002253 acid Substances 0.000 title abstract 2
150000003839 salts Chemical class 0.000 title abstract 2
WPJRFCZKZXBUNI-HCWXCVPCSA-N daunosamine Chemical compound C[C@H](O)[C@@H](O)[C@@H](N)CC=O WPJRFCZKZXBUNI-HCWXCVPCSA-N 0.000 abstract 5
YOFDHOWPGULAQF-UHFFFAOYSA-N Daunomycin-Aglycone Natural products C1C(O)(C(C)=O)CC(O)C2=C1C(O)=C1C(=O)C(C=CC=C3OC)=C3C(=O)C1=C2O YOFDHOWPGULAQF-UHFFFAOYSA-N 0.000 abstract 4
LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 abstract 3
YOFDHOWPGULAQF-MQJDWESPSA-N (7s,9s)-9-acetyl-6,7,9,11-tetrahydroxy-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione Chemical compound C1[C@@](O)(C(C)=O)C[C@H](O)C2=C1C(O)=C1C(=O)C(C=CC=C3OC)=C3C(=O)C1=C2O YOFDHOWPGULAQF-MQJDWESPSA-N 0.000 abstract 2
TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 abstract 2
PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 abstract 2
230000008878 coupling Effects 0.000 abstract 2
238000010168 coupling process Methods 0.000 abstract 2
238000005859 coupling reaction Methods 0.000 abstract 2
PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 abstract 2
125000006239 protecting group Chemical group 0.000 abstract 2
238000006137 acetoxylation reaction Methods 0.000 abstract 1
125000003277 amino group Chemical group 0.000 abstract 1
230000031709 bromination Effects 0.000 abstract 1
238000005893 bromination reaction Methods 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000003840 hydrochlorides Chemical class 0.000 abstract 1
238000007086 side reaction Methods 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK96203554T 1996-12-16 1996-12-16 Fremgangsmåde til fremstilling af epirubicin eller syreadditionssalte deraf ud fra daunorubicin DK0848009T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP96203554A EP0848009B1 (de)	1996-12-16	1996-12-16	Verfahren zur Herstellung von Epirubicin oder Zusatzsalzen davon, von Daunorubicin

Publications (1)

Publication Number	Publication Date
DK0848009T3 true DK0848009T3 (da)	2000-11-20

Family

ID=8224702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96203554T DK0848009T3 (da)	1996-12-16	1996-12-16	Fremgangsmåde til fremstilling af epirubicin eller syreadditionssalte deraf ud fra daunorubicin

Country Status (11)

Country	Link
US (1)	US5874550A (de)
EP (1)	EP0848009B1 (de)
JP (1)	JP4176845B2 (de)
AT (1)	ATE195526T1 (de)
CA (1)	CA2224764C (de)
DE (1)	DE69609845T2 (de)
DK (1)	DK0848009T3 (de)
ES (1)	ES2151632T3 (de)
GR (1)	GR3034608T3 (de)
PT (1)	PT848009E (de)
SI (1)	SI0848009T1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100785966B1 (ko) *	2000-08-10	2007-12-14	동아제약주식회사	안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
KR100850408B1 (ko) *	2000-08-10	2008-08-04	동아제약주식회사	안트라싸이클린계 항암제인 에피루비신 및 약학적으로허용되는 그 염의 제조방법
CN100412084C (zh) *	2003-07-02	2008-08-20	獀洛克斯股份有限公司	热稳定的结晶盐酸表柔比星及其制造方法
US20090099346A1 (en) *	2003-07-02	2009-04-16	Victor Matvienko	Thermally stable crystalline epirubicin hydrochloride
US7388083B2 (en) *	2005-03-07	2008-06-17	Solux Corporation	Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
WO2006111561A1 (en) *	2005-04-21	2006-10-26	Dsm Ip Assets B.V.	Improved microbial production of anthracyclins
RU2450013C2 (ru) *	2005-12-13	2012-05-10	Солюкс Корпорейшен	Способ получения 4-деметилдаунорубицина
US8802830B2 (en) *	2005-12-20	2014-08-12	Solux Corporation	Synthesis of epirubicin from 13-dihydrodaunorubicine
PL1990405T3 (pl) *	2007-05-08	2018-01-31	Provivo Oy	Genetycznie zmodyfikowane szczepy wytwarzające metabolity będące antracyklinami użyteczne jako leki przeciwnowotworowe
US8357785B2 (en) *	2008-01-08	2013-01-22	Solux Corporation	Method of aralkylation of 4′-hydroxyl group of anthracylins
AU2008361598B2 (en) *	2008-09-11	2015-02-12	Heraeus Precious Metals Gmbh & Co Kg	Genetically modified strains for biotransformations in anthracycline production
EP2636676A3 (de)	2009-09-08	2014-01-01	Heraeus Precious Metals GmbH & Co. KG	Kristallisierung von Epidaunorubicin x HCI
KR101125460B1 (ko)	2010-03-24	2012-03-28	동아제약주식회사	에피루비신 염산염의 신규한 결정형
DE102011103751A1 (de)	2011-05-31	2012-12-06	Heraeus Precious Metals Gmbh & Co. Kg	Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) *	2011-08-30	2013-02-28	Lead Discovery Center Gmbh	Neue Cyclosporin-Derivate
WO2015000132A1 (zh)	2013-07-02	2015-01-08	浙江海正药业股份有限公司	表阿霉素的制备方法及其中间体
WO2016159092A1 (ja)	2015-03-30	2016-10-06	ＭｅｉｊｉＳｅｉｋａファルマ株式会社	エピルビシンの製造方法およびその新規な製造中間体
CN104861014B (zh) *	2015-06-03	2017-09-29	道中道（菏泽）制药有限公司	一种盐酸表阿霉素结晶的制备方法
WO2017120729A1 (zh) *	2016-01-11	2017-07-20	浙江海正药业股份有限公司	一种盐酸表柔比星的制备方法及其中间体
CN112574267A (zh) *	2019-09-28	2021-03-30	鲁南制药集团股份有限公司	一种盐酸表柔比星中间体化合物iii
CN114149473B (zh) *	2020-09-08	2024-03-15	鲁南制药集团股份有限公司	一种盐酸表柔比星的合成方法及其中间体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3803124A (en)	1968-04-12	1974-04-09	Farmaceutici It Soc	Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
GB1457632A (en)	1974-03-22	1976-12-08	Farmaceutici Italia	Adriamycins
JPS61502956A (ja)	1984-06-14	1986-12-18	ビオガル　ジヨジセルジヤ−ル	アドリアマイシン及びそのハロゲン化塩の調整法
GB8519452D0 (en) *	1985-08-02	1985-09-11	Erba Farmitalia	Injectable solutions
IT1196503B (it)	1986-07-16	1988-11-16	Erba Farmitalia	Procedimento continuo per la trasformazione di 4'-cheto-n-trifluoroacetildaunorubicina in 4'-epi-trifluoroacetildaunorubicina,internmedio per la preparazione di un composto
IT1230505B (it) *	1988-10-11	1991-10-25	Sicor Spa	Procedimento per la conversione della daunorubicina in doxorubicina.
IT1275953B1 (it) *	1995-03-22	1997-10-24	Sicor Spa	Procedimento per la preparazione di antibiotici della classe delle antracicline

1996
- 1996-12-16 DE DE69609845T patent/DE69609845T2/de not_active Expired - Fee Related
- 1996-12-16 ES ES96203554T patent/ES2151632T3/es not_active Expired - Lifetime
- 1996-12-16 DK DK96203554T patent/DK0848009T3/da active
- 1996-12-16 EP EP96203554A patent/EP0848009B1/de not_active Expired - Lifetime
- 1996-12-16 AT AT96203554T patent/ATE195526T1/de not_active IP Right Cessation
- 1996-12-16 PT PT96203554T patent/PT848009E/pt unknown
- 1996-12-16 SI SI9630241T patent/SI0848009T1/xx unknown
1997
- 1997-01-14 JP JP00494697A patent/JP4176845B2/ja not_active Expired - Fee Related
- 1997-12-04 US US08/985,358 patent/US5874550A/en not_active Expired - Fee Related
- 1997-12-15 CA CA002224764A patent/CA2224764C/en not_active Expired - Fee Related
2000
- 2000-10-12 GR GR20000402292T patent/GR3034608T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0848009B1 (de)	2000-08-16
CA2224764A1 (en)	1998-06-16
JPH10175991A (ja)	1998-06-30
ES2151632T3 (es)	2001-01-01
EP0848009A1 (de)	1998-06-17
CA2224764C (en)	2006-10-03
ATE195526T1 (de)	2000-09-15
GR3034608T3 (en)	2001-01-31
PT848009E (pt)	2000-11-30
DE69609845T2 (de)	2000-12-21
DE69609845D1 (de)	2000-09-21
SI0848009T1 (en)	2000-12-31
JP4176845B2 (ja)	2008-11-05
US5874550A (en)	1999-02-23

Publication	Publication Date	Title
DK0848009T3 (da)	2000-11-20	Fremgangsmåde til fremstilling af epirubicin eller syreadditionssalte deraf ud fra daunorubicin
ES2061479T3 (es)	1994-12-16	Aminouretanos, procedimiento de obtencion y usos.
DK0754231T3 (da)	2006-10-23	Peptidfragment fra G-proteinet fra respiratorisk syncytialvirus, immunogent middel, farmaceutisk præparat, der indeholder det, og fremgangsmåde til fremstilling deraf
IE860305L (en)	1986-08-01	Method for purifying antihemophilic factor
PT938467E (pt)	2002-11-29	Processo para a preparacao de isomeros opticamente puros de formoterol
JPS6410997A (en)	1989-01-13	Polysaccharide and production thereof
PT785950E (pt)	2003-09-30	Analogos do factor de crescimento de queratinocitos
DK0980248T3 (da)	2001-11-19	Forbedringer af eller vedrørende langtidsvirkende antibiotika
ATE62250T1 (de)	1991-04-15	Cytidine-diphosphocholine salze, besonders geeignet fuer oralen gebrauch.
IL117047A0 (en)	1996-06-18	Method for purifying diacetylrhein
DK0827966T3 (da)	2002-05-21	Fremstilling af oprensede (poly)peptider
FR2752833B1 (fr)	1998-12-11	Procede de preparation d'un borate de terre rare par reaction d'au moins un sel de terre rare, d'acide borique et d'une base
CA2130618A1 (en)	1995-02-26	Stereoselective process for preparing .beta.-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonate intermediates
DK0524143T3 (da)	1998-08-24	Fremgangsmåde til fremstilling af aktiverede sialinsyrer
MX9207468A (es)	1993-06-01	Proceso para preparar acido 2,6-naftalenodicarboxilico purificado.
MA21305A1 (fr)	1988-12-31	Procede de preparation de l'acide (pyridyl-3)-3 ih,3h-pyrrono(i,2-c) thiazolecarboxylique-7 dextrocyre.
BR9811579A (pt)	2000-08-22	Processo para preparação de ácidos 3-ciano-2,4-dialógeno-5-fluorobenzóicos
KR890008159A (ko)	1989-07-10	4-데메톡시 안트라사이클린 유도체
PT1061067E (pt)	2004-06-30	Processo para a cristalizacao e recolha de n-omega-trifluoroacetil aminoacidos basicos
IT8120245A0 (it)	1981-03-10	Processo per la preparazione di 11-(2'-sostituito)-acetil-5,11-diidro-6h-pirido-(2,3-b)(1,4)-benzodiazepin-6-oni.
RU94017615A (ru)	1997-02-27	Способ получения пептида
JPS5686184A (en)	1981-07-13	Novel mitomycin c derivative
JPS57145845A (en)	1982-09-09	Novel peptide and its preparation
JPS57118595A (en)	1982-07-23	Novel antibiotic substance cystamycin and its preparation
PE58499A1 (es)	1999-06-14	Metodo de purificacion de 1,3,5-triisopropilbenceno